Low risk — use of or exposure to this product is not likely to cause adverse health consequences.
PCA Skin Blemish Control Bar Recalled by Island Kinetics, Inc. d.b.a. CoValence Laboratories Due to Superpotent Drug: Salicylic acid content is above the...
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Island Kinetics, Inc. d.b.a. CoValence Laboratories directly.
Affected Products
PCA Skin Blemish Control Bar, 3.2 oz/90g, Salicylic acid 2% - Acne cleanser, For external use only, Distributed by PCA Skin, 6210 E. Thomas Rd., Ste. 200, Scottsdale, AZ 85251; UPC 812025010397.
Quantity: 2542 units
Why Was This Recalled?
Superpotent Drug: Salicylic acid content is above the firm's specification.
Where Was This Sold?
This product was distributed to 1 state: AZ
About Island Kinetics, Inc. d.b.a. CoValence Laboratories
Island Kinetics, Inc. d.b.a. CoValence Laboratories has 1 total recall tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report